CMD Bioscience seeks to leverage its assets into partnerships with leading biotech and pharma companies.

We are actively seeking custom contract work and licensing opportunities, and we welcome inquiries from prospective collaborators and investors.  Our proprietary algorithms, especially when interfaced with commercially available software, can be used to solve a number of important problems associated with the development of clinically relevant compounds.  For example, working with our clients we can:

1. Predict if and how two proteins will interact
2. Identify “hot spot” residues at protein-protein interfaces
3. Predict how chemical modifications will impact protein-protein complex stability
4. Predict the water-membrane partitioning behavior of proteins and peptides
5. Identify lead peptides and peptidomimetics
6. Optimize lead peptides and peptidomimetics

For more information, please contact:

Joseph Audie, Ph.D.
Chief Executive Officer
CMD Bioscience LLC
joseph.audie@cmdbioscience.com
203-640-0501